For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241010:nRSJ7686Ha&default-theme=true
RNS Number : 7686H Kelso Group Holdings PLC 10 October 2024
10 October 2024
Kelso Group Holdings Plc
("Kelso" or the "Company")
Comment on THG Plc
Kelso, the main market listed acquisition vehicle, notes the announcement from
THG Plc ('THG') at 4.52pm today regarding the early advancement of its plans
to demerge Ingenuity and the associated placing. THG is Kelso's second largest
shareholding.
Kelso believes in Ingenuity's model and its long term future and that the
demerger will be highly beneficial for Ingenuity, as well as for THG Beauty
and MyProtein as the remaining parts of THG. Kelso believes that the value of
the two remaining businesses are each worth more than the current market
capitalisation of THG.
Kelso is also supportive of the placing announced today and pleased with the
board's speed of execution and decisive action. Kelso intends to participate
in the placing.
For further information please contact:
Kelso Group Holdings plc +44 (0) 75 4033 3933
John Goold, Chief Executive Officer
Mark Kirkland, Chief Financial Officer
Jamie Brooke, Chief Investment Officer
Zeus (Broker) +44 (0) 20 3829 5000
Nick Cowles, Ed Beddows, John Moran (Investment Banking)
Ben Robertson (Corporate Broking)
Camarco +44 (0) 20 3757 4980
Billy Clegg, Tom Huddart
About Kelso
Kelso was established in November 2022 to identify, engage and unlock trapped
value in the UK stock market. Kelso's strategy is to invest in situations
where it believes there is an anomaly between the intrinsic value and
prospects of a company and its stock market valuation. Kelso will, in
particular, look for situations where it believes the sum of the parts of a
business is greater than the current value. The Kelso team is led by an
experienced and well-invested Board and management team with a track record of
identifying and creating value in the UK small and mid-cap public markets.
There may be instances where Kelso itself could be used as a vehicle by an
undervalued company to spin off a subsidiary into its own listing. The board
of Kelso owns 20.5% of the equity having invested in each of the last three
fundraising rounds.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END SPCMMBATMTABBRI